These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2972068

  • 1. Radionuclide evaluation of renal transplants.
    Dubovsky EV, Russell CD.
    Semin Nucl Med; 1988 Jul; 18(3):181-98. PubMed ID: 2972068
    [Abstract] [Full Text] [Related]

  • 2. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
    Russell CD, Thorstad BL, Stutzman ME, Yester MV, Fowler D, Dubovsky EV.
    Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR, Robbins MS.
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [Abstract] [Full Text] [Related]

  • 5. 99mTc-MAG3, a new renal imaging agent: preliminary results in patients.
    Taylor A, Eshima D, Alazraki N.
    Eur J Nucl Med; 1987 Dec; 12(10):510-4. PubMed ID: 2952506
    [Abstract] [Full Text] [Related]

  • 6. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
    Bubeck B, Brandau W, Steinbächer M, Reinbold F, Dreikorn K, Eisenhut M, Georgi P.
    Int J Rad Appl Instrum B; 1988 Dec; 15(1):109-18. PubMed ID: 2965116
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM, Penglis S, Bellen JC, Baker RJ, Chatterton BE.
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Parametric representation of kidney function using 99mTc-mercaptoacetyltriglycine (MAG3)].
    Szabó Z, Kutkuhn B, Georgescu G, Mecklenbeck W, Suatmadji A, Vosberg H.
    Nuklearmedizin; 1989 Jun; 28(3):73-83. PubMed ID: 2525703
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I, Sueyoshi K, Sugioka Y, Komori T, Ogura Y, Tabuchi K, Nakata Y, Namba R, Tatsu Y, Matsui R.
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A, Eshima D.
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [Abstract] [Full Text] [Related]

  • 20. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA, Britton KE, Nimmon CC, Solanki K, Al-Nahhas A, Bomanji J, Fettich J, Hawkins LA.
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.